Arsenal Holdings plc (the "Company") confirms that, as announced by the Company
on 30 March 2009, it has been notified that on that date Stan Kroenke, a
director of the Company, had a beneficial holding of 12,756 ordinary shares of
£1 each in the capital of the Company ("Shares") (representing 20.5 per cent.
of the total issued share capital of the Company). The Company's announcement
on 30 March 2009 did not contain the details of 42 Shares which had recently
been acquired by Mr Kroenke. Those Shares were acquired by Mr Kroenke in five
separate transactions between 6 March 2009 and 23 March 2009 (with settlement
dates between 6 March 2009 and 6 April 2009) at prices of between £7,600 per
Share and £7,800 per Share.
In addition, the Company announces that it has today been notified that on 1
April 2009 Mr Kroenke acquired a further 18 Shares at a price of £7,800 per
Share. Following that transaction, Mr Kroenke has a beneficial holding of
12,774 Shares (representing 20.5 per cent. of the total issued share capital of
the Company).
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.